Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
- Chng ti giao hng tn ni, thanh ton trc tip khi nhn hng, nu b li, b c th i tr trong 15 ngy
Reviews claiming dramatic weight loss without mentioning caloric restriction are either conflating correlation with causation or are not disclosing other interventions
How to Get to Our Location Hours: Monday: 8 AM12:30 PM, 25 PM Tuesday: 8 AM12:30 PM, 25 PM Wednesday: 8 AM12:30 PM, 25 PM Thursday : 8 AM12:30 PM, 25 PM Friday: 8 AM12:30 PM Saturday: Closed Sunday: Closed Our office is located off of US76 / W Palmetto St, near the McLeod Urgent Care Center